Foundation Medicine Announces 2017 Second Quarter Results and Recent Highlights
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/13/2026
- S&P 500 ends higher as strong inflation data cements rate-hike bets
- Oracle raises full year profit guidance, stock rises after hours
- Oil falls but head for 8% weekly gain on tight supply; US diesel hits record
- 'No panic anywhere' may be the problem, BofA strategists warn
- Buy Shopify stock at this ’AI-enabled entry point,’ analyst says
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
Foundation Medicine (FMI) Misses Q2 EPS by 13c
August 1, 2017 4:29 PM EDTFoundation Medicine (NASDAQ: FMI) reported Q2 EPS of ($1.24), $0.13 worse than the analyst estimate of ($1.11). Revenue for the quarter came in at $35 million versus the consensus estimate of $34.94 million.
GUIDANCE:
Foundation Medicine sees FY2017 revenue of $135-145 million, versus the consensus of... More
